Stem Cell Banking Market Size to Worth USD 24.68 Bn by 2033

June 28, 2024 Prathamesh

The global stem cell banking market size is expected to increase USD 24.68 billion by 2033 from USD 5.78 billion in 2023 with a CAGR of 15.63% between 2024 and 2033.

Key Points

The North America stem cell banking market size reached USD 2.02 billion in 2023 and is expected to attain around USD 8.76 billion by 2033, poised to grow at a CAGR of 15.80% between 2024 and 2033.
North America registered the largest revenue share in 2023.
By utilization, the unused segment dominated the market in 2023 and is expected to grow at a rapid pace during the forecast period.
By utilization, the used segment will grow at the fastest rate in the market over the forecast period.
By cell type, the umbilical cord stem cell segment held the largest share of the market in 2023.
By cell type, the adult stem cell segment will grow at the fastest rate in the market over the forecast period.
By service type, in 2023, the storage segment held the largest share of the market.
By service type, the processing segment will grow at the fastest rate in the market over the forecast period.
By bank, the private bank segment dominated the global market in 2023.
By bank, the public bank segment is anticipated to show the fastest growth in the market over the foreseeable period.

The Stem Cell Banking Market involves the preservation of stem cells derived from various sources, including umbilical cord blood and tissue, bone marrow, and adipose tissue. These cells are stored for potential future therapeutic use, offering a valuable resource for regenerative medicine and research purposes.

Get a Sample: https://www.precedenceresearch.com/sample/4558

List of Contents

Growth Factors

The market growth is driven by increasing awareness about the therapeutic potential of stem cells, advancements in biobanking technologies, and rising investments in stem cell research. Moreover, growing applications in treating chronic diseases and genetic disorders propel market expansion.

Stem Cell Banking Market Trends

Rising Awareness and Acceptance: Increasing awareness about the potential of stem cells in treating various diseases and injuries is driving demand for stem cell banking services.
Technological Advancements: Advances in stem cell preservation techniques, such as cryopreservation, are improving the viability and longevity of stored stem cells, boosting market growth.
Growing Investments: Increased funding and investment in research and development of stem cell therapies are expanding the market size and scope.
Expanding Applications: Stem cells are increasingly being used in regenerative medicine and cell therapy applications, broadening the market’s potential across different therapeutic areas.
Regulatory Developments: Evolving regulatory frameworks and guidelines concerning the collection, storage, and therapeutic use of stem cells are shaping market dynamics and consumer confidence.
Personalized Medicine: The shift towards personalized medicine is fostering demand for personalized stem cell banking services, where stem cells are stored for potential future use by individuals and their families.

Region Insights

North America and Europe dominate the market due to established healthcare infrastructure, supportive regulatory frameworks, and high awareness levels among the population. Meanwhile, the Asia-Pacific region shows rapid growth, driven by improving healthcare facilities and rising disposable incomes.

Stem Cell Banking Market Scope

Report Coverage	Details
Market Size by 2033	USD 24.68 Billion
Market Size in 2023	USD 5.78 Billion
Market Size in 2024	USD 6.68 Billion
Market Growth Rate from 2024 to 2033	CAGR of 15.63%
Largest Market	North America
Base Year	2023
Forecast Period	2024 to 2033
Segments Covered	Service Type, Utilization, Cell Type, Bank Type, and Regions
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Stem Cell Banking Market Dynamics

Drivers:

Key drivers include the rising prevalence of chronic diseases requiring stem cell therapies, advancements in personalized medicine, and increasing public and private investments in biotechnology and healthcare sectors.

Opportunities:

Opportunities lie in expanding applications of stem cells in treating neurodegenerative diseases, cardiovascular disorders, and oncology. Additionally, technological innovations in cryopreservation techniques and growing partnerships between research institutes and biobanks present promising avenues.

Challenges:

Challenges include ethical concerns regarding embryonic stem cell research, high costs associated with stem cell banking and therapy, and regulatory complexities across different regions. Moreover, ensuring the long-term viability and quality of stored stem cells poses logistical and scientific challenges.

Stem Cell Banking Market Companies

Cordlife
Cryo-Save AG
Stemcyte
Smart Cells International Ltd.
Cordvida
CBR Systems Inc.
Lifecell
Cryoviva India
Cryo-Cell
Viacord

Recent Developments

In September 2023, the leading fertility and women’s health company CooperSurgical revealed that Cord Blood Registry® (CBR®) will play a major part in the next Cord Blood Connect meeting, which is the annual meeting of the Cord Blood Association and takes place from September 8–11.
In May 2024, the Abu Dhabi Biobank opened, revealing the area’s largest hybrid cord blood bank. This ground-breaking project and strategic priority aims to transform healthcare in the area.

Segment Covered in the Report

By Service Type